Yee Chao Selected Research

Ligands

3/2023	Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062.
1/2023	Elevated PD-L1 Expression and Microsatellite Instability in Elderly Patients With Gastric Cancer.
1/2022	Microsatellite Instability, Epstein-Barr Virus, and Programmed Cell Death Ligand 1 as Predictive Markers for Immunotherapy in Gastric Cancer.
1/2004	A G-quadruplex ligand 3,3'-diethyloxadicarbocyanine iodide induces mitochondrion-mediated apoptosis but not decrease of telomerase activity in nasopharyngeal carcinoma NPC-TW01 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yee Chao Research Topics

Disease

87	Neoplasms (Cancer) 01/2024 - 05/2003
60	Hepatocellular Carcinoma (Hepatoma) 06/2024 - 05/2003
30	Stomach Neoplasms (Stomach Cancer) 10/2023 - 05/2002
18	Adenocarcinoma 03/2023 - 08/2005
12	Neoplasm Metastasis (Metastasis) 12/2023 - 05/2003
9	Disease Progression 01/2023 - 05/2012
8	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 03/2011
8	Carcinoma (Carcinomatosis) 01/2022 - 09/2004
8	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 07/2002
7	Fever (Fevers) 01/2016 - 03/2005
6	Colonic Neoplasms (Colon Cancer) 01/2021 - 05/2007
6	Neutropenia 01/2018 - 09/2003
5	Gastric Outlet Obstruction 01/2022 - 12/2012
5	Fibrosis (Cirrhosis) 01/2022 - 01/2016
5	Carcinogenesis 05/2020 - 01/2013
4	Hypertension (High Blood Pressure) 01/2024 - 10/2013
4	Microsatellite Instability 01/2023 - 12/2019
4	Fatigue 01/2016 - 03/2005
3	Infections 04/2024 - 01/2019
3	Rectal Neoplasms (Rectal Cancer) 06/2021 - 03/2005
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 12/2003
3	Vomiting 05/2018 - 09/2003
3	Diarrhea 05/2018 - 03/2013
3	Nausea 05/2018 - 09/2003
3	Cholangiocarcinoma 03/2017 - 01/2013
3	Inflammation (Inflammations) 01/2016 - 09/2005
3	Leukemia 03/2012 - 01/2004
2	Hepatitis 04/2024 - 04/2021
2	Proteinuria 01/2024 - 01/2018
2	Anemia 01/2024 - 09/2013
2	Lymphatic Metastasis 10/2023 - 03/2017
2	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 03/2012
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 10/2022 - 01/2016
2	Brain Stem Neoplasms (Brain Stem Tumor) 04/2022 - 02/2020
2	Duodenal Obstruction 01/2022 - 01/2020
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2022 - 09/2004
2	Brain Neoplasms (Brain Tumor) 04/2021 - 06/2020
2	Hepatitis B 02/2021 - 08/2007

Drug/Important Bio-Agent (IBA)

22	Sorafenib (BAY 43-9006)FDA Link 06/2024 - 03/2013
15	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 07/2002
13	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2019
13	NivolumabIBA 10/2022 - 12/2017
12	Cisplatin (Platino)FDA LinkGeneric 09/2022 - 07/2002
11	Gemcitabine FDA Link 10/2022 - 09/2003
9	pembrolizumabIBA 09/2023 - 04/2017
9	alpha-Fetoproteins (alpha-Fetoprotein)IBA 07/2023 - 12/2009
8	Immune Checkpoint InhibitorsIBA 01/2024 - 11/2019
8	Leucovorin (Folinic Acid)FDA Link 01/2022 - 07/2002
7	BilirubinIBA 07/2023 - 01/2018
7	AlbuminsIBA 07/2023 - 01/2018
7	Proteins (Proteins, Gene)FDA Link 12/2021 - 07/2007
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 05/2003
6	Docetaxel (Taxotere)FDA Link 01/2016 - 08/2005
6	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2015 - 01/2008
5	Trastuzumab (Herceptin)FDA Link 12/2023 - 12/2014
5	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 12/2012
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2016 - 12/2009
4	B7-H1 AntigenIBA 03/2023 - 06/2020
4	LigandsIBA 03/2023 - 01/2004
4	Antiviral Agents (Antivirals)IBA 10/2022 - 01/2017
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2022 - 12/2018
4	regorafenibIBA 04/2022 - 01/2020
4	CytokinesIBA 08/2021 - 09/2005
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 05/2012
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2024 - 12/2014
3	AntigensIBA 02/2020 - 03/2017
3	PlatinumIBA 01/2020 - 01/2016
3	Phosphotransferases (Kinase)IBA 08/2019 - 03/2012
3	Serum AlbuminIBA 12/2018 - 12/2014
3	RamucirumabIBA 04/2018 - 03/2016
3	Capecitabine (Xeloda)FDA Link 01/2017 - 04/2014
3	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2016 - 10/2013
3	TegafurIBA 06/2011 - 03/2005
3	Etoposide (VP 16)FDA LinkGeneric 11/2009 - 07/2002
2	Tumor Biomarkers (Tumor Markers)IBA 07/2023 - 07/2018
2	Circulating Tumor DNAIBA 01/2023 - 01/2020
2	margetuximabIBA 01/2023 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2023 - 06/2021
2	lenvatinibIBA 10/2022 - 01/2022
2	Tenofovir (Viread)FDA Link 09/2022 - 12/2018
2	entecavir FDA Link 09/2022 - 12/2018
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 03/2011
2	tislelizumabIBA 01/2022 - 01/2020
2	ProdrugsIBA 12/2021 - 06/2011
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2021 - 05/2013
2	AntibodiesIBA 02/2021 - 12/2017
2	CreatinineIBA 02/2021 - 12/2018
2	Indicators and Reagents (Reagents)IBA 01/2021 - 12/2019

Therapy/Procedure

46	Therapeutics 01/2024 - 07/2002
45	Drug Therapy (Chemotherapy) 03/2023 - 07/2002
11	Radiotherapy 04/2024 - 03/2005
8	Immunotherapy 01/2024 - 03/2005
7	Gastrectomy 01/2023 - 08/2011
5	Stents 01/2022 - 12/2012
4	Self Expandable Metallic Stents 01/2022 - 07/2015
4	Chemoradiotherapy 01/2015 - 09/2003
3	Boron Neutron Capture Therapy 04/2022 - 06/2020
2	Microspheres (Microsphere) 04/2024 - 04/2021
2	Salvage Therapy 01/2022 - 01/2020
2	Aftercare (After-Treatment) 01/2022 - 01/2018